Prescribing Information

Prescribing Information - most related articles:

- TNF blockers will have boxed warning cancer risk - 3.4
- Microsoft's HealthVault for AMA physicians in US - 3.1
- Education of clinicians improves prescribing for high blood pressure patients - 2.8
- Tussionex cough medicine with hydrocodone warning - 2.8
- Boxed warning required for Chantix and Zyban, says FDA - 2.5
- FDA reviewing stimulant medications for ADHD - 2.4
- New safety controls for asthma drugs, US - 2.4
- Safety changes in labeling for cholesterol lowering drugs statins - 2.3
- New drug labels better for pregnant & nursing mothers - 2.2
- Purchasing contact lenses online is risky - 2.1

Prescribing Information articles

TNF blockers will have boxed warning cancer risk
The U.S. Food and Drug Administration is requiring stronger warnings in the prescribing information for a class of drugs known as TNF blockers or TNF inhibitors.

Ortho Evra contraceptive transdermal birth control patch label update
The U.S. Food and Drug Administration (FDA) approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills. VTE can lead to pulmonary embolism.

2 Prescribing Information articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.07